Balanced news tone
News Sentiment
4521 sentiment intelligence
Kaken Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+0.4% over one week, -0.5% over four weeks, trend inactive, and near fair-value range.
Kaken Pharmaceutical Co., Ltd. Financial Disclosures & Filings
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Kaken Pharmaceutical Co., Ltd. Financial Disclosures & Filings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 14:02
- Source
- TradingView
CymaBay Therapeutics Announces Collaboration with Kaken
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jan 2023 08:00
- Source
- GlobeNewswire
Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Feb 2018 08:00
- Source
- PR Newswire